Codice QR

CRISPR/Cas9-based Engineering of Immunoglobulin Loci in Hybridoma Cells

Development of the hybridoma technology by Köhler and Milstein (1975) has revolutionized the immunological field by enabling routine use of monoclonal antibodies (mAbs) in research and development efforts, resulting in their successful application in the clinic today. While recombinant good manufact...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Camille Le Gall, Felix Fennemann, Johan van der Schoot, Ferenc Scheeren, Martijn Verdoes
Natura: Artigo
Lingua:Inglês
Pubblicazione: Bio-protocol LLC 2023-02-01
Serie:Bio-Protocol
Accesso online:https://bio-protocol.org/en/bpdetail?id=4613&type=0
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!